Andrew Harrison
Follow
Get notifications in MyBN when activity occurs.
Andrew Harrison
Chief Executive / Resonance Health
Most Notable Role
Andrew Harrison is an experienced chief executive and non-executive director of public-listed and private companies across a range of industries including radiology and medical artificial intelligence.
Mr Harrison also has extensive experience in capital market transactions, technology commercialisation, local and international mergers and acquisitions, strategic restructuring and turnaround. He has substantial
international experience in European, US, and Chinese markets.
Mr Harrison was the founder and managing director of ASX-listed Capitol Health, one of Australia’s largest radiology companies. He became chief executive of Resonance Health in July 2023.
Mr Harrison also has extensive experience in capital market transactions, technology commercialisation, local and international mergers and acquisitions, strategic restructuring and turnaround. He has substantial
international experience in European, US, and Chinese markets.
Mr Harrison was the founder and managing director of ASX-listed Capitol Health, one of Australia’s largest radiology companies. He became chief executive of Resonance Health in July 2023.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 536th | Proteomics International Laboratories | 8% | 26% |
| 628th | Resonance Health | 3% | -7% |
| 840th | HITIQ | -7% | |
| 1612th | Nuheara | -60% | -44% |
| 1835th | Emyria | -78% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
07/07/10
$0 Bought
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 123rd |  | Resonance Health | $4.5m |
| 130th | | Emyria | $3.8m |
| 131st | | Nuheara | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 136th | | Proteomics International Laboratories | $3.2m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Resonance acquires TrialsWest | 02 Apr 2024 |
| NEWS: Tagged in Resonance Health scores $6m contract | 18 Aug 2023 |
| NEWS: Tagged in Board Moves June 23, 2023 | 23 Jun 2023 |
| NEW ROLE: Chief Executive, Resonance Health | 23 Jun 2023 |
